Literature DB >> 10563722

Nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity as an etiology for lipodystrophy.

T N Kakuda, R C Brundage, P L Anderson, C V Fletcher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10563722     DOI： 10.1097/00002030-199911120-00019

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  23 in total

1.  Clinical, laboratory, and neuroimaging characteristics of fatigue in HIV-infected individuals.

Authors:  Giovanni Schifitto; Lijuan Deng; Tzu-Min Yeh; Scott R Evans; Thomas Ernst; Jianhui Zhong; David Clifford
Journal:  J Neurovirol       Date:  2010-12-23       Impact factor: 2.643

2.  Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy.

Authors:  Steve A Castillo; Jaime E Hernandez; Cindy H Brothers
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  HIV-associated lipodystrophy syndrome: A review of clinical aspects.

Authors:  Jean-Guy Baril; Patrice Junod; Roger Leblanc; Harold Dion; Rachel Therrien; Franãois Laplante; Julian Falutz; Pierre Côté; Marie-Nicole Hébert; Richard Lalonde; Normand Lapointe; Dominic Lévesque; Lyse Pinault; Danielle Rouleau; Cécile Tremblay; Benoãt Trottier; Sylvie Trottier; Chris Tsoukas; Karl Weiss
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-07       Impact factor: 2.471

Review 4.  Mitochondrial toxicity and HIV therapy.

Authors:  A J White
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

Review 5.  Pathogenesis and treatment of HIV lipohypertrophy.

Authors:  Vivien L Leung; Marshall J Glesby
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

Review 6.  The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications.

Authors:  Oliver P Flint; Mustafa A Noor; Paul W Hruz; Phil B Hylemon; Kevin Yarasheski; Donald P Kotler; Rex A Parker; Aouatef Bellamine
Journal:  Toxicol Pathol       Date:  2009-01-26       Impact factor: 1.902

7.  Beneficial Effects of Cannabis on Blood-Brain Barrier Function in Human Immunodeficiency Virus.

Authors:  Ronald J Ellis; Scott Peterson; Mariana Cherner; Erin Morgan; Rachel Schrier; Bin Tang; Martin Hoenigl; Scott Letendre; Jenny Iudicello
Journal:  Clin Infect Dis       Date:  2021-07-01       Impact factor: 9.079

8.  Weight change after antiretroviral therapy and mortality.

Authors:  Bianca Yuh; Janet Tate; Adeel A Butt; Kristina Crothers; Matthew Freiberg; David Leaf; Mary Logeais; David Rimland; Maria C Rodriguez-Barradas; Christopher Ruser; Amy C Justice
Journal:  Clin Infect Dis       Date:  2015-03-11       Impact factor: 9.079

Review 9.  Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.

Authors:  Erdembileg Anuurad; Alison Semrad; Lars Berglund
Journal:  Metab Syndr Relat Disord       Date:  2009-10       Impact factor: 1.894

10.  Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.

Authors:  B Lindegaard; P Keller; H Bruunsgaard; J Gerstoft; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.